34 Stocks Moving In Tuesday's Mid-Day Session

Gainers

• TherapeuticsMD, Inc. TXMD jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due to menopause.
• NexTier Oilfield Solutions Inc. NEX jumped 21.6% to $4.7050 after the company issued an operational update and guidance for the fourth quarter. The company said it expects Q4 revenue of $500-$510 million, reflecting a surge of more than 25% from Q3 2021.
• Winc, Inc. WBEV rose 19% to $6.91.
• Heritage Insurance Holdings, Inc. HRTG jumped 13.9% to $6.71 after the company announced a $25 million buyback.
• Immix Biopharma, Inc. IMMX shares gained 13.8% to $6.57 on continued momentum after the U.S. Food and Drug Administration granted Rare Pediatric Disease designation for IMX-110 for the treatment of rhabdomyosarcoma, a life-threatening form of pediatric cancer in children.
• New York City REIT, Inc. NYC jumped 13.8% to $12.30.
• Oragenics, Inc. OGEN rose 13.5% to $0.5364. The company reported in Form 4 filing that Director Robert Koski bought 1 million shares at an average price of $0.47 per share.
• Reviva Pharmaceuticals Holdings, Inc. RVPH gained 11.7% to $3.24.
• Aravive, Inc. ARAV rose 11.4% to $2.73.
• NeuroBo Pharmaceuticals, Inc. NRBO rose 11.3% to $1.4695 after gaining around 10% on Monday.
• Ford Motor Company F gained 10.5% to $24.06 after the company announced it plans to nearly double production of the F-150 Lightning all-electric truck.
• REE Automotive Ltd. REE jumped 9.7% to $6.12.
• Agrify Corporation AGFY gained 8.4% to $10.47. Agrify announced Tuesday that it has inked a definitive agreement for its largest Agrify Total Turn-Key Solution partnership to date with Gold Leaf Florida LLC.
• iSpecimen Inc. ISPC shares gained 8.4% to $8.74 after Craig-Hallum initiated coverage on the stock with a Buy rating and $20 price target.
• Reata Pharmaceuticals, Inc. RETA rose 8% to $29.50.
• Co-Diagnostics, Inc. CODX shares surged 7.7% to $10.03. Hearing Zack's named the stock as under $10 service buy.

Check out these big penny stock gainers and losers

Losers

• Zhangmen Education Inc. ZME shares dropped 41.3% to $2.65.
• AVROBIO, Inc. AVRO shares fell 35.2% to $2.62 after the company reported it is shifting its portfolio priorities to focus on other clinical-stage programs and extending its cash runway into the first quarter of 2024. It is deprioritizing its Fabry disease program.
• Gritstone bio, Inc. GRTS fell 35% to $7.92 as the company shared data from the first cohort (10 µg dose) of the Phase 1 booster trial of self-amplifying mRNA (samRNA) COVID-19 vaccine.
• Genprex, Inc. GNPX fell 24.7% to $2.63. Genprex expanded gene therapy oncology pipeline to include small cell lung cancer.
• Heliogen, Inc. HLGN dropped 22.6% to $10.50 after declining around 13% on Monday.
• iCAD, Inc. ICAD dipped 21.6% to $5.86 after the company issued Q4 and FY21 sales guidance below estimates.
• Valneva SE VALN fell 21.4% to $40.06. Valneva, last month, said its COVID-19 vaccine candidate was efficient as a booster for people who had received the same shot as an initial vaccination.
• Creative Medical Technology Holdings, Inc. CELZ shares fell 20.2% to $2.5550 after jumping around 45% on Monday.
• Jowell Global Ltd. JWEL fell 18.4% to $7.18 after dipping around 60% on Monday.
• Pear Therapeutics, Inc. PEAR shares declined 14.3% to $6.54. BTIG, on Monday, initiated coverage on the stock with a Buy rating and announced a $12 price target.
• Dada Nexus Limited DADA dropped 13.5% to $11.39. Shares of Chinese companies traded lower in reaction to new Chinese cybersecurity rules from February 15.
• Global-e Online Ltd. GLBE shares fell 13.2% to $55.00.
• Intra-Cellular Therapies, Inc. ITCI shares fell 12.5% to $45.50 after the company reported a $400 million common stock offering.
• Everspin Technologies, Inc. MRAM shares dropped 12.1% to $11.22.
• Trio-Tech International TRT shares declined 11.1% to $11.06.
• Armstrong Flooring, Inc. AFI fell 9% to $2.5201. Armstrong Flooring shares climbed around 40% on Monday after the company said it is exploring a sale of the business.
• Abcam plc ABCM shares fell 8.3% to $21.92. Alamar Biosciences and Abcam reported a strategic partnership to further understanding of the human proteome.
• Tiziana Life Sciences PLC TLSA shares fell 6.3% to $1.0213 after climbing around 14% on Monday.